Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06566911 · ClinicalTrials.gov registry record

Voice Analysis for Monitoring Patients With Heart Failure

A clinical trial of Heart Failure, sponsored by Noah Labs.

Recruiting
Registry status
70
Enrollment target
2
Study locations

NCT06566911: Recruiting study of Heart Failure, sponsored by Noah Labs.

NCT06566911 is a study of Heart Failure that is actively recruiting participants, run by Noah Labs. The registered enrollment target is 70 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06566911, a study of Heart Failure, is actively recruiting participants, sponsored by Noah Labs.

RECRUITING
Registry status
70 participants
Enrollment target
2
Study locations

Study Summary

This observational study involves ADHF patients at two sites in the United States and Germany. After informed consent and screening assessments, participants will perform daily voice recordings during their hospital stay, from admission until discharge. Alongside voice data, additional clinical information such as left ventricular ejection fraction, NTpro-BNP levels, and ECG-data will be collected for comprehensive analysis. The study's goal is to identify voice-based indicators of heart failure progression, with the potential to enhance remote monitoring and self-management strategies for heart failure patients.

Conditions Studied

Study Locations (2)

Minnesota

  • Mayo Clinic - Rochester

Other

  • Deutsches Herzzentrum der Charité - Berlin

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2024-01-24
Est. Completion 2024-09

Sponsor

Noah Labs

2 total trials

What the Registry Record Tells You About NCT06566911

The ClinicalTrials.gov registry entry for NCT06566911 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (97% lower). The listed sponsor is Noah Labs, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 0 interventions.

NCT06566911 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Minnesota, Other.

Frequently Asked Questions

What is clinical trial NCT06566911 about?

NCT06566911 is a clinical study titled "Voice Analysis for Monitoring Patients With Heart Failure". This observational study involves ADHF patients at two sites in the United States and Germany. After informed consent and screening assessments, participants will perform daily voice recordings during their hospital stay, from admission until discharge. Alongside voice data, additional clinical info...

What is the current status of trial NCT06566911?

This trial is currently recruiting. The enrollment target is 70 participants. The study started on 2024-01-24. Estimated completion is 2024-09.

What conditions does trial NCT06566911 study?

This clinical trial studies the following conditions: Heart Failure.

Who is sponsoring clinical trial NCT06566911?

This trial is sponsored by Noah Labs, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06566911 being conducted?

This trial has 2 study locations across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.